publication venue for
- 18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer. 39:100583-100583. 2023
- Adaptive radiotherapy for breast cancer. 39:100564-100564. 2023
- Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial. 37:145-152. 2022
- Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI. 32:41-47. 2022